The results indicated that the FDE regimen raised the radioresistance of MFR-surviving NSCLC transformed cells irrespectively of their p53 status, though the HF regimen demonstrated a similar effect on p53null NSCLC transformed cells only. The gene discussed is TP53; the disease is non-small cell lung carcinoma.